Wernberg, C.W.; Ravnskjaer, K.; Lauridsen, M.M.; Thiele, M.
The Role of Diagnostic Biomarkers, Omics Strategies, and Single-Cell Sequencing for Nonalcoholic Fatty Liver Disease in Severely Obese Patients. J. Clin. Med. 2021, 10, 930.
https://doi.org/10.3390/jcm10050930
AMA Style
Wernberg CW, Ravnskjaer K, Lauridsen MM, Thiele M.
The Role of Diagnostic Biomarkers, Omics Strategies, and Single-Cell Sequencing for Nonalcoholic Fatty Liver Disease in Severely Obese Patients. Journal of Clinical Medicine. 2021; 10(5):930.
https://doi.org/10.3390/jcm10050930
Chicago/Turabian Style
Wernberg, Charlotte W., Kim Ravnskjaer, Mette M. Lauridsen, and Maja Thiele.
2021. "The Role of Diagnostic Biomarkers, Omics Strategies, and Single-Cell Sequencing for Nonalcoholic Fatty Liver Disease in Severely Obese Patients" Journal of Clinical Medicine 10, no. 5: 930.
https://doi.org/10.3390/jcm10050930
APA Style
Wernberg, C. W., Ravnskjaer, K., Lauridsen, M. M., & Thiele, M.
(2021). The Role of Diagnostic Biomarkers, Omics Strategies, and Single-Cell Sequencing for Nonalcoholic Fatty Liver Disease in Severely Obese Patients. Journal of Clinical Medicine, 10(5), 930.
https://doi.org/10.3390/jcm10050930